Antigua and Barbuda vs Sur: Previously treated cases tested for RR-/MDR-TB
Antigua and Barbuda
100.0%
in 2022
Sur
62.0%
in 2024
Antigua and Barbuda rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Antigua and Barbuda
- Sur
How they compare
Antigua and Barbuda currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Antigua and Barbuda's figure about 1.6 times Sur's.
The two have swapped places 2 times across 5 shared years of data; in 2009 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 1st and Sur ranks 2nd of 180 countries.
Across the 3 decades both report, Antigua and Barbuda averaged higher in 2 and Sur in 1.
Head to head by decade
| Decade | Antigua and Barbuda | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 50.0% | 0.0% | 50.0% | Antigua and Barbuda |
| 2010s | 0.0% | 7.3% | 7.3% | Sur |
| 2020s | 100.0% | 80.0% | 20.0% | Antigua and Barbuda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Antigua and Barbuda or Sur?
- Antigua and Barbuda, at 100.0% against 62.0% in Sur as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Antigua and Barbuda and Sur?
- 38.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and Sur?
- 5 years are reported by both, from 2009 to 2022.
- How do Antigua and Barbuda and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Antigua and Barbuda ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.